Acute myeloid leukemia measurable residual disease detection by flow cytometry in peripheral blood vs bone marrow.

Godwin, Colin D; Zhou, Yi; Othus, Megan; Asmuth, Mallette M; Shaw, Carole M; Gardner, Kelda M; Wood, Brent L; Walter, Roland B; Estey, Elihu H

Godwin, Colin D; Zhou, Yi; Othus, Megan; Asmuth, Mallette M; Shaw, Carole M; Gardner, Kelda M; Wood, Brent L; Walter, Roland B; Estey, Elihu H.

Affiliation

Godwin CD; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Zhou Y; Department of Medicine, Division of Hematology, and.
Othus M; Department of Laboratory Medicine, Division of Hematopathology, University of Washington, Seattle, WA.
Asmuth MM; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and.
Shaw CM; Internal Medicine Residency Program.
Gardner KM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Wood BL; Department of Medicine, Division of Hematology, and.
Walter RB; Department of Laboratory Medicine, Division of Hematopathology, University of Washington, Seattle, WA.
Estey EH; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.

Blood ; 137(4): 569-572, 2021 01 28.

Article in En | MEDLINE | ID: mdl-33507294

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow / Leukemia, Myeloid, Acute / Flow Cytometry / Neoplastic Cells, Circulating Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2021 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google